Legislation Introduced to Spur Treatments for Brain Ailments

If enacted, sponsors say measure could double or triple the number of neurotherapies on the market















Share on Tumblr

brain illness scan doctor

A GROWING PROBLEM: Lawmakers are stepping in to try to speed the development of treatments for brain-related illnesses, which affect 100 million Americans and cost more than $1 trillion per year to manage. Image: © ISTOCKPHOTO/DON BAYLEY

  • The Wisdom of Psychopaths

    In this engrossing journey into the lives of psychopaths and their infamously crafty behaviors, the renowned psychologist Kevin Dutton reveals that there is a...

    Read More »

Lawmakers yesterday introduced legislation designed to speed the development of new, safer therapies for brain and nervous system disorders and injuries, which affect an estimated 100 million Americans and costs an estimated $1.3 trillion annually to treat.

The National Neurotechnology Initiative Act (NNTI), which has bipartisan support, calls for $200 million in federal funds to be set aside annually to research potential treatments and to establish a clearinghouse for information from federal agencies to help them better coordinate efforts. The lawmakers charge that a lack of coordination has impeded development of treatments for brain-related illnesses.

The funds would also go toward coordinating the work of 16 branches within the NIH that study brain-related injuries as well as to add and train employees at the Food and Drug Administration, which has been accused of dragging its feet on drug approvals because it is, among other things, woefully understaffed.

"Recent discoveries are revolutionizing our understanding of the human brain, and new uses for these discoveries are emerging almost every day," said Sen. Patty Murray (D-WA) who, along with Sen. Pete Domenici (R-N.M.), introduced the bill in the Senate. "The current research system for neurological diseases is disjointed and often limits this life-altering research from reaching the patients in need."

Researchers applauded the legislation. Zack Lynch, founder and executive director of the Neurotechnology Industry Organization (NIO), a recently formed trade association of small companies and organizations dedicated to brain research, says it has the potential of tripling the number of new drugs that make it onto the market by pooling brain- and man-power.

"For a modest investment," he said, "Congress has the opportunity to streamline research efforts, accelerate the development of new treatments, promote innovation by small businesses, and have a meaningful impact on the lives of those suffering from devastating diseases and injuries."

Murray says the measure is particularly crucial now, because scores of soldiers have returned from Iraq and Afghanistan with severe head and spinal injuries, as well as post-traumatic stress disorder.

"The time has arrived to offer a serious and comprehensive legislative approach to help the countless Americans struggling and living with brain and nervous system illnesses," said Rep. Ileana Ros-Lehtinen (R–Fla.), who co-sponsored the House measure with Rep. Patrick Kennedy (D-R.I.). "To not act on this important issue is to relegate millions of our citizens to second class status and a lifetime of disabilities."

The bill has been referred to the Senate Committee on Health, Education, Labor and Pensions, which is chaired by Kennedy's father, Massachusetts Democratic Sen. Ted Kennedy. In the House, it is headed to the Committee on Energy and Commerce.



1 Comments

Add Comment
View
  1. 1. progon 05:58 PM 5/11/08

    I have huntington's disease and this is good news. The funding for HD research that created the HD centers of excellence is a prime example of government doing the right thing instead of doing the politically correct thing of ignoring brain research because it might add to the science base and a cure for diseases that are not from the corporate but university sector.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

Follow Us:

See what we're tweeting about

Scientific American MIND

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Science Jobs of the Week

Email this Article

Legislation Introduced to Spur Treatments for Brain Ailments

X
Scientific American Mind

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X